|
1
|
Biological, clinical and population relevance of 95 loci for blood lipids.
|
Nature
|
2010
|
28.21
|
|
2
|
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
|
Lancet
|
2002
|
23.18
|
|
3
|
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.
|
Nat Genet
|
2011
|
13.25
|
|
4
|
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.
|
Lancet
|
2012
|
12.10
|
|
5
|
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.
|
Nat Genet
|
2012
|
11.09
|
|
6
|
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
|
N Engl J Med
|
2009
|
8.73
|
|
7
|
Large-scale association analysis identifies new risk loci for coronary artery disease.
|
Nat Genet
|
2012
|
7.59
|
|
8
|
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
|
Lancet
|
2002
|
6.87
|
|
9
|
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
|
Lancet
|
2012
|
4.87
|
|
10
|
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways.
|
Nat Genet
|
2012
|
4.73
|
|
11
|
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
|
Lancet
|
2012
|
4.63
|
|
12
|
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.
|
Nat Genet
|
2012
|
4.37
|
|
13
|
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.
|
Nat Genet
|
2014
|
4.13
|
|
14
|
Association of apolipoprotein E genotypes with lipid levels and coronary risk.
|
JAMA
|
2007
|
4.03
|
|
15
|
Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility.
|
Nat Genet
|
2005
|
3.86
|
|
16
|
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
|
Ann Intern Med
|
2003
|
3.78
|
|
17
|
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
|
JAMA
|
2002
|
3.70
|
|
18
|
The Swedish Twin Registry in the third millennium: an update.
|
Twin Res Hum Genet
|
2006
|
3.58
|
|
19
|
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies.
|
Nat Genet
|
2010
|
3.37
|
|
20
|
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.
|
Nat Genet
|
2013
|
3.25
|
|
21
|
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.
|
PLoS Genet
|
2012
|
3.21
|
|
22
|
Common variants associated with plasma triglycerides and risk for coronary artery disease.
|
Nat Genet
|
2013
|
2.92
|
|
23
|
Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits.
|
PLoS Genet
|
2013
|
2.83
|
|
24
|
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
|
Hypertension
|
2005
|
2.69
|
|
25
|
Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension.
|
Hypertension
|
2003
|
2.35
|
|
26
|
Long term exposure to ambient air pollution and incidence of acute coronary events: prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE Project.
|
BMJ
|
2014
|
2.30
|
|
27
|
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.
|
J Am Coll Cardiol
|
2013
|
2.18
|
|
28
|
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways.
|
Nat Genet
|
2012
|
2.12
|
|
29
|
Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
|
Ann Intern Med
|
2003
|
2.09
|
|
30
|
Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.
|
J Rheumatol
|
2012
|
2.08
|
|
31
|
Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population) study.
|
J Am Coll Cardiol
|
2012
|
1.96
|
|
32
|
Association between height and coronary heart disease mortality: a prospective study of 35,000 twin pairs.
|
Am J Epidemiol
|
2006
|
1.85
|
|
33
|
Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility.
|
Circulation
|
2010
|
1.75
|
|
34
|
Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration.
|
Eur Heart J
|
2011
|
1.73
|
|
35
|
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.
|
Am J Epidemiol
|
2008
|
1.71
|
|
36
|
The Swedish Twin Registry: establishment of a biobank and other recent developments.
|
Twin Res Hum Genet
|
2012
|
1.65
|
|
37
|
Body mass index and mortality: is the association explained by genetic factors?
|
Epidemiology
|
2011
|
1.58
|
|
38
|
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction.
|
Eur Heart J
|
2004
|
1.54
|
|
39
|
Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.53
|
|
40
|
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
|
J Hypertens
|
2004
|
1.53
|
|
41
|
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
|
Hypertension
|
2004
|
1.52
|
|
42
|
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
|
J Hypertens
|
2002
|
1.51
|
|
43
|
Factors associated with uncontrolled hypertension and cardiovascular risk in hypertensive 60-year-old men and women--a population-based study.
|
Hypertens Res
|
2009
|
1.50
|
|
44
|
Job strain and major risk factors for coronary heart disease among employed males and females in a Swedish study on work, lipids and fibrinogen.
|
Scand J Work Environ Health
|
2002
|
1.50
|
|
45
|
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
|
Hypertension
|
2005
|
1.49
|
|
46
|
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
|
J Hypertens
|
2009
|
1.48
|
|
47
|
Phenotype selection for detecting variable genes: a survey of cardiovascular quantitative traits and TNF locus polymorphism.
|
Eur J Hum Genet
|
2007
|
1.45
|
|
48
|
Does menopausal hormone therapy reduce myocardial infarction risk if initiated early after menopause? A population-based case-control study.
|
Menopause
|
2015
|
1.39
|
|
49
|
[Reply from the SBU about salt and high blood pressure: More controlled long-term trials are required].
|
Lakartidningen
|
2004
|
1.38
|
|
50
|
Seven modifiable lifestyle factors predict reduced risk for ischemic cardiovascular disease and all-cause mortality regardless of body mass index: a cohort study.
|
Int J Cardiol
|
2012
|
1.35
|
|
51
|
Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.
|
Arthritis Rheum
|
2004
|
1.34
|
|
52
|
Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study.
|
PLoS Genet
|
2009
|
1.34
|
|
53
|
Multilocus genetic risk scores for coronary heart disease prediction.
|
Arterioscler Thromb Vasc Biol
|
2013
|
1.32
|
|
54
|
Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective.
|
Int J Technol Assess Health Care
|
2007
|
1.30
|
|
55
|
Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
|
Atherosclerosis
|
2005
|
1.25
|
|
56
|
The importance of non-exercise physical activity for cardiovascular health and longevity.
|
Br J Sports Med
|
2013
|
1.24
|
|
57
|
Genetic and shared environmental factors do not confound the association between birth weight and hypertension: a study among Swedish twins.
|
Circulation
|
2007
|
1.23
|
|
58
|
Investigating air pollution and atherosclerosis in humans: concepts and outlook.
|
Prog Cardiovasc Dis
|
2011
|
1.19
|
|
59
|
Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2013
|
1.18
|
|
60
|
Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study.
|
Eur Heart J
|
2009
|
1.17
|
|
61
|
Long-term exposure to ambient air pollution and incidence of cerebrovascular events: results from 11 European cohorts within the ESCAPE project.
|
Environ Health Perspect
|
2014
|
1.16
|
|
62
|
Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
|
Biochem Biophys Res Commun
|
2002
|
1.15
|
|
63
|
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism.
|
J Am Coll Cardiol
|
2012
|
1.14
|
|
64
|
Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.
|
Am J Epidemiol
|
2012
|
1.13
|
|
65
|
Haplotypes extending across ACE are associated with Alzheimer's disease.
|
Hum Mol Genet
|
2003
|
1.11
|
|
66
|
Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men.
|
Atherosclerosis
|
2008
|
1.10
|
|
67
|
Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden.
|
Stroke
|
2010
|
1.09
|
|
68
|
Work related stressful life events and the risk of myocardial infarction. Case-control and case-crossover analyses within the Stockholm heart epidemiology programme (SHEEP).
|
J Epidemiol Community Health
|
2005
|
1.05
|
|
69
|
Genetic and environmental influences on decline in biobehavioral markers of aging.
|
Behav Genet
|
2003
|
1.04
|
|
70
|
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.
|
Blood Press
|
2004
|
1.04
|
|
71
|
Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia.
|
Arterioscler Thromb Vasc Biol
|
2013
|
1.03
|
|
72
|
Genetic influences on angina pectoris and its impact on coronary heart disease.
|
Eur J Hum Genet
|
2007
|
1.01
|
|
73
|
Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
|
Eur J Cardiovasc Prev Rehabil
|
2009
|
1.00
|
|
74
|
Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
|
Arthritis Res Ther
|
2010
|
0.99
|
|
75
|
Genetic epidemiology of spontaneous subarachnoid hemorrhage: Nordic Twin Study.
|
Stroke
|
2010
|
0.99
|
|
76
|
Genetic susceptibility of myocardial infarction.
|
Twin Res Hum Genet
|
2007
|
0.99
|
|
77
|
Arterial blood pressure and long-term exposure to traffic-related air pollution: an analysis in the European Study of Cohorts for Air Pollution Effects (ESCAPE).
|
Environ Health Perspect
|
2014
|
0.98
|
|
78
|
Hospital readmission after coronary artery bypass grafting: are women doing worse?
|
Ann Thorac Surg
|
2002
|
0.97
|
|
79
|
Multivitamin supplements are inversely associated with risk of myocardial infarction in men and women--Stockholm Heart Epidemiology Program (SHEEP).
|
J Nutr
|
2003
|
0.96
|
|
80
|
Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.95
|
|
81
|
Risk factors associated with newly diagnosed high blood pressure in men and women.
|
Am J Hypertens
|
2008
|
0.92
|
|
82
|
Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk.
|
Circ Cardiovasc Genet
|
2012
|
0.92
|
|
83
|
Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.
|
Thromb Haemost
|
2009
|
0.92
|
|
84
|
Genetic dominance influences blood biomarker levels in a sample of 12,000 Swedish elderly twins.
|
Twin Res Hum Genet
|
2009
|
0.91
|
|
85
|
Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men.
|
J Nutr
|
2004
|
0.91
|
|
86
|
A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity.
|
Hum Mol Genet
|
2004
|
0.90
|
|
87
|
The risk of type 2 diabetes in men is synergistically affected by parental history of diabetes and overweight.
|
PLoS One
|
2013
|
0.89
|
|
88
|
IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes.
|
Int J Cardiol
|
2012
|
0.89
|
|
89
|
Cost-effectiveness of primary prevention of coronary heart disease through risk factor intervention in 60-year-old men from the county of Stockholm--a stochastic model of exercise and dietary advice.
|
Prev Med
|
2003
|
0.89
|
|
90
|
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.
|
Pharmacogenet Genomics
|
2010
|
0.88
|
|
91
|
The interaction between coagulation factor 2 receptor and interleukin 6 haplotypes increases the risk of myocardial infarction in men.
|
PLoS One
|
2010
|
0.88
|
|
92
|
Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women.
|
Metab Syndr Relat Disord
|
2009
|
0.88
|
|
93
|
Prevalence of hypertension in immigrants and Swedish-born individuals, a cross-sectional study of 60-year-old men and women in Sweden.
|
J Hypertens
|
2008
|
0.87
|
|
94
|
Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.
|
Hum Genet
|
2004
|
0.87
|
|
95
|
Incidence and case fatality after day 28 of first time myocardial infarction in Sweden 1987-2008.
|
Eur J Prev Cardiol
|
2011
|
0.87
|
|
96
|
Genetic influences on CHD-death and the impact of known risk factors: comparison of two frailty models.
|
Behav Genet
|
2004
|
0.87
|
|
97
|
The metabolic syndrome and left ventricular hypertrophy--the influence of gender and physical activity.
|
Blood Press
|
2011
|
0.86
|
|
98
|
Common and low-frequency genetic variants in the PCSK9 locus influence circulating PCSK9 levels.
|
Arterioscler Thromb Vasc Biol
|
2012
|
0.86
|
|
99
|
Do genetic factors explain the association between poor oral health and cardiovascular disease? A prospective study among Swedish twins.
|
Am J Epidemiol
|
2009
|
0.85
|
|
100
|
Air pollution and atherosclerosis: a cross-sectional analysis of four European cohort studies in the ESCAPE study.
|
Environ Health Perspect
|
2015
|
0.84
|
|
101
|
Decreased risk for myocardial infarction and lower tumor necrosis factor-alpha levels in carriers of variants of the PDCD1 gene.
|
Hum Immunol
|
2006
|
0.84
|
|
102
|
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.
|
J Clin Hypertens (Greenwich)
|
2005
|
0.84
|
|
103
|
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
|
Curr Med Res Opin
|
2007
|
0.84
|
|
104
|
Low levels of antibodies against phosphorylcholine in Alzheimer's disease.
|
J Alzheimers Dis
|
2010
|
0.83
|
|
105
|
A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness).
|
Diabetologia
|
2014
|
0.83
|
|
106
|
The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.
|
J Am Coll Cardiol
|
2005
|
0.83
|
|
107
|
The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project.
|
Thromb Res
|
2005
|
0.83
|
|
108
|
Plasma NT-proBNP concentration is related to ambulatory pulse pressure in peripheral arterial disease.
|
Blood Press
|
2005
|
0.83
|
|
109
|
Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk.
|
J Lipid Res
|
2011
|
0.83
|
|
110
|
Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study.
|
Clin Exp Rheumatol
|
2011
|
0.83
|
|
111
|
Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study.
|
Am Heart J
|
2008
|
0.83
|
|
112
|
The myeloperoxidase gene and its influence on myocardial infarction in a Swedish population: protective role of the -129A allele in women.
|
Coron Artery Dis
|
2009
|
0.83
|
|
113
|
Financial stress in late adulthood and diverse risks of incident cardiovascular disease and all-cause mortality in women and men.
|
BMC Public Health
|
2014
|
0.82
|
|
114
|
Hematocrit and mean arterial blood pressure in pre- and postmenopause women.
|
Vasc Health Risk Manag
|
2009
|
0.82
|
|
115
|
Causal relevance of blood lipid fractions in the development of carotid atherosclerosis: Mendelian randomization analysis.
|
Circ Cardiovasc Genet
|
2012
|
0.82
|
|
116
|
Circulating oxidized low-density lipoprotein is increased in hypertension.
|
Clin Sci (Lond)
|
2003
|
0.81
|
|
117
|
Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.
|
Diabetologia
|
2015
|
0.81
|
|
118
|
Identification of a functional apolipoprotein E promoter polymorphism regulating plasma apolipoprotein E concentration.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.81
|
|
119
|
Repeated blood pressure measurements in a sample of Swedish twins: heritabilities and associations with polymorphisms in the renin-angiotensin-aldosterone system.
|
J Hypertens
|
2002
|
0.81
|
|
120
|
Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study.
|
BMC Cardiovasc Disord
|
2013
|
0.80
|
|
121
|
Association between metabolic effects and tobacco use in 60-year-old Swedish men.
|
Eur J Epidemiol
|
2008
|
0.80
|
|
122
|
Evidence that the gene encoding insulin degrading enzyme influences human lifespan.
|
Hum Mol Genet
|
2008
|
0.80
|
|
123
|
PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP).
|
Thromb Haemost
|
2003
|
0.79
|
|
124
|
Genetic and environmental regulation of inflammatory CVD biomarkers Lp-PLA2 and IgM anti-PC.
|
Atherosclerosis
|
2011
|
0.79
|
|
125
|
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study.
|
Blood Press
|
2009
|
0.79
|
|
126
|
The effect of leisure-time physical activity on the risk of acute myocardial infarction depending on body mass index: a population-based case-control study.
|
BMC Public Health
|
2006
|
0.79
|
|
127
|
Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients.
|
Arterioscler Thromb Vasc Biol
|
2007
|
0.79
|
|
128
|
Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP).
|
Eur J Cardiovasc Prev Rehabil
|
2007
|
0.78
|
|
129
|
Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2002
|
0.78
|
|
130
|
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
|
Circulation
|
2005
|
0.78
|
|
131
|
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
|
Metabolism
|
2008
|
0.77
|
|
132
|
Apolipoprotein C-I genotype and serum levels of triglycerides, C-reactive protein and coronary heart disease.
|
Metabolism
|
2010
|
0.77
|
|
133
|
Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
|
Expert Opin Emerg Drugs
|
2005
|
0.77
|
|
134
|
Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.
|
Thromb Res
|
2011
|
0.77
|
|
135
|
Functional changes in adipose tissue in a randomised controlled trial of physical activity.
|
Lipids Health Dis
|
2012
|
0.77
|
|
136
|
Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels.
|
BMC Cardiovasc Disord
|
2012
|
0.77
|
|
137
|
Elevated ApoB serum levels strongly predict early cardiovascular events.
|
Heart
|
2012
|
0.77
|
|
138
|
Telomere length is associated with ACE I/D polymorphism in hypertensive patients with left ventricular hypertrophy.
|
J Renin Angiotensin Aldosterone Syst
|
2012
|
0.76
|
|
139
|
A gene-centric study of common carotid artery remodelling.
|
Atherosclerosis
|
2012
|
0.76
|
|
140
|
Genes and environment behind ethnical differences in variations in left ventricular mass.
|
J Hypertens
|
2004
|
0.75
|
|
141
|
Likelihood of treatment in a coronary care unit for a first-time myocardial infarction in relation to sex, country of birth and socioeconomic position in Sweden.
|
PLoS One
|
2013
|
0.75
|
|
142
|
Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study.
|
PLoS Genet
|
2016
|
0.75
|
|
143
|
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men.
|
Atherosclerosis
|
2007
|
0.75
|
|
144
|
Interaction between air pollution exposure and genes in relation to levels of inflammatory markers and risk of myocardial infarction.
|
BMJ Open
|
2013
|
0.75
|
|
145
|
Anti-atherosclerotic effects by AT1 receptor blockade.
|
J Hypertens
|
2003
|
0.75
|
|
146
|
Job strain and plasminogen activator inhibitor-1: results from the Swedish WOLF study.
|
Int Arch Occup Environ Health
|
2004
|
0.75
|
|
147
|
Myocardial ischaemia in patients with peripheral arterial disease.
|
Clin Physiol Funct Imaging
|
2007
|
0.75
|
|
148
|
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
|
J Am Coll Cardiol
|
2005
|
0.75
|
|
149
|
Clinical prediction of normotension in borderline hypertensive men--a 10 year study.
|
J Hypertens
|
2004
|
0.75
|
|
150
|
Genome-wide search for QTLs for apolipoprotein A-I level in elderly Swedish DZ twins: evidence of female-specific locus on 15q11-13.
|
Eur J Hum Genet
|
2008
|
0.75
|
|
151
|
Familial effects on survival after myocardial infarction: a registry-based sib-pair study.
|
Eur J Epidemiol
|
2012
|
0.75
|
|
152
|
Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
|
Blood Press
|
2005
|
0.75
|